Molecular Formula: C
56H
87NO
16 Molecular Weight: 1030.28708
InChIKey: CBPNZQVSJQDFBE-FUXHJELOSA-N
Temsirolimus is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the FDA in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative of sirolimus and is sold as Torisel.
From: DrugBank